Individualized Medicine in Ovarian Cancer: Are We There Yet?
نویسندگان
چکیده
منابع مشابه
[Role of individualized dosing in oncology: are we there yet?].
There is no personalized anticancer treatment without individualized dosing. Clearly, BSA-based chemotherapy dosing does not improve the substantial pharmacokinetic variability of individual drugs. Similarly, the new oral kinase inhibitors and endocrine compounds exhibit a marked pharmacokinetic variability due to variable absorption, hepatic metabolism and potential drug-drug and food-drug int...
متن کاملCancer immunotherapy: are we there yet?
The immune system is the built-in host defense mechanism against infectious agents as well as cancer. Protective immunity against cancer was convincingly demonstrated in the 1940s with syngeneic animal models (JNCI 18:769-778, 1976; Cancer Immun 1:6, 2001). Since then, the last century's dream has been to effectively prevent and cure cancers by immunological means. This dream has slowly but sur...
متن کامل"Are we there yet?".
Changes in laws are reflected – even foreshadowed on occasion – by the field’s scholarship. In the 1980s, there were few who recognized that adults with disabilities were an important resource in the education of students with disabilities or that issues of race and culture had consequence for identifying and delivering services to these children. It is striking that this special issue of the L...
متن کاملAre We There Yet?
Statistical approaches to Artificial Intelligence are behind most success stories of the field in the past decade. The idea of generating non-trivial behaviour by analysing vast amounts of data has enabled recommendation systems, search engines, spam filters, optical character recognition, machine translation and speech recognition, among other things. As we celebrate the spectacular achievemen...
متن کاملBreast Cancer Vaccine: Are We There Yet?
In lieu of an abstract, here is the article's first paragraph: Breast cancer is the most fatal form of cancer for female population worldwide. National Cancer Institute (NCI) estimates 226,870 females and 2,190 males to be diagnosed with breast cancer in the United States by the end of 2012. The estimated death toll for this year includes 39,510 females and 410 males, as reported by NCI. Statis...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Gynecologic Oncology
سال: 2017
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2017.01.006